Cardiovascular (CV) and Malignancy Events in the Filgotinib Rheumatoid Arthritis (RA) Clinical Development Program up to 8.3 Years.

Autor:in

Mariette, Xavier; Borchmann, Sven; Aspeslagh, Sandrine; Calvo-Alen, Jaime; Moriggl, Richard; Szekanecz, Zoltan; De Leonardis, Francesco; Verbruggen, Nadia; Van Hoek, Paul; Schmalzing, Marc; Stallmach, Andreas; Charles-Schoeman, Christina; Rajendran, Vijay; Rudolph, Christine; Watson, Chris; Tanaka, Yoshiya; Choy, Ernest

Dokumenten­typ

Abstract

DOI

10.1002/art.42700

Titel des Sammel­werks

ARTHRITIS & RHEUMATOLOGY;

Konferenz­name / Titel der Ver­anstaltung

ACR Convergence 2023

Konferenz­datum

November 10-15, 2023